Pulmatrix Initiates European Pilot Bioequivalence Study of PUR0200 for COPD

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. SPY
3. APTX:CN
4. IQMX
5. EROC
6. MSTR
7. TSLA
8. MSFT
9. SEER
10. NVDA

Go back to Pulmatrix Initiates European Pilot Bioequivalence Study of PUR0200 for COPD
(NASDAQ: PULM) Delayed: 1.73 +0.01 (0.58%)
Previous Close $1.72    52 Week High $5.56 
Open $1.67    52 Week Low $0.76 
Day High $1.74    P/E N/A 
Day Low $1.66    EPS $0.00 
Volume 18,473